The US complex & chronic condition management market was exceeded US$ 3.2 Billion in 2021 and is projected to reach US$ 8.7 billion by 2027, up 18 percent Year-Over-Year (2021-2027), according to a 2022 study by Precedence Research, the Canada-based market Insight Company.
COVID-19 had significantly changed the status quo for the healthcare industry in US. The terms such as eHealth, telehealth, and telemedicine gained a rapid traction. The consumers were highly affected due to the lockdown measures and the risk of getting infected that compelled the US population to adopt telehealth services, especially among those who are suffering from various chronic diseases and need frequent consultations and monitoring. The complex and chronic condition management solutions gained a rapid popularity and the demand for it was fueled due to the pandemic in 2020.
The rising government investments in the development of smart hospitals by equipping the healthcare units with digital and advanced technologies. The technologies like telehealth, internet, smartphones, and other digital devices are the major factors that contributes in the overall development of the ecosystem for the complex & chronic condition management services across the US. Moreover, the presence of strong and develop telecommunications and IT infrastructure in the country is significantly fueling the adoption of the chronic condition management solutions among the US population.
Download the FREE Sample Report (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1455
Scope of the U.S. Complex and Chronic Condition Management Market
| Report Coverage | Details |
| Market Size In 2020 | US$ 2.7 Billion |
| Growth Rate From 2021 to 2027 | CAGR of 18% |
| Revenue Projection in 2027 | US$ 8.7 Billion |
| Base Year | 2021 |
| Forecast Period | 2021 To 2027 |
| Fastest Growing Market | United State |
| Segments Covered | Service, Disease Type, Region |
Report Highlights
- Chronic Obstructive Pulmonary Disease (COPD) are expected to be the most opportunistic segment during the forecast period. The rising prevalence of the COPD among the US population is boosting the growth. It is estimated that around 14.8 million adults in US have been diagnosed with COPD in 2020. This is expected to drive the growth of this segment in the forthcoming years.
- The implementation services dominated the market with 34.2% market share in 2020. The rapidly rising incidences of various chronic diseases and growing geriatric population in US is resulting in the increased volume of tests and clinical visits. The telehealth platforms facilitates in the appointment fixation in a convenient way. Moreover, the number of consumers is rapidly growing on the various telehealth platforms, which is expected to significantly boost the growth of the market.
Rising adoption of the telehealth platforms
According to the American Hospital Association, the telehealth platforms helps in connecting the patients to the essential healthcare services through wireless communications, online video conferencing, remote monitoring, and electronic consults. The physicians are increasingly accessing to the telehealth platforms that helps the patients to acquire right treatment at right time. As per the American Hospital Association, around 76% of the hospitals in US communicates with their patients and practitioners, who are located at a distant place via telehealth platforms. Therefore, the increasing adoption of the telehealth platforms across the healthcare industry in US is estimated to drive the growth of the complex and chronic condition management market.
Increased government intervention
There is a potential risk that the government may change the clinical workflow of the hospitals, practitioners, and various other healthcare stakeholders that can limit the utilization of the telehealth services. The government policies highly influences the activities or actions of the clients and partners of the telehealth service providers. Hence, any change in the healthcare policies in US may have a negative impact on the growth of the complex and chronic condition management market in the foreseeable future.
Rising government investments in digitalization of healthcare industry
The federal government is investing heavily in digitalizing the healthcare sector in US to reduce the pressure on the hospitals and boost the operational efficiency of the healthcare units. The digitization of the hospitals can effectively reduce the time consumed for a treatment procedure and can save costs. The US government has recognized the importance of the digital healthcare system and the role of innovation in the healthcare sector as an important part of the successful health care facilities. The US government announced to invest US$ 80 million to create health informatics program in 2021.
Healthcare fraud and security of patient information
Rising number of cyberattacks may result in the financial loses to both the consumers and the service providers. The market players are investing on resolving the issues related to cyberattacks and data security. The cyberattacks may also lead to the death of the patient. Therefore, the major issues like healthcare frauds and data security may hamper the growth of the US complex and chronic condition management market during the forecast period.
Some of the prominent players in the global US complex & chronic condition management market include:
- AllScripts
- Siemens Healthineers
- Koninklijke Philips N.V.
- Pegasystems, Inc.
- Cognizant TriZetto Software Group Inc.
- IBM Corporation
- ScienceSoft USA
- MINES & Associates, Inc.
- Healthcare at Home
- Mediware Information Systems
Segments Covered in the Report
By Disease Type
- Cardiovascular Diseases
- Oncology
- Musculoskeletal
- Women’s Health/Fertility/Maternity
- Chronic Obstructive Pulmonary Disease
- Others
By Service
- Consulting Service
- Implementation Service
- Education Service
- Others
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Complex & Chronic Condition Management Market
5.1. COVID-19 Landscape: Complex & Chronic Condition Management Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Complex & Chronic Condition Management Market, By Disease
8.1. Complex & Chronic Condition Management Market, by Disease Type, 2021-2027
8.1.1. Cardiovascular Diseases
8.1.1.1. Market Revenue and Forecast (2017-2027)
8.1.2. Oncology
8.1.2.1. Market Revenue and Forecast (2017-2027)
8.1.3. Musculoskeletal
8.1.3.1. Market Revenue and Forecast (2017-2027)
8.1.4. Women’s Health/Fertility/Maternity
8.1.4.1. Market Revenue and Forecast (2017-2027)
8.1.5. Chronic Obstructive Pulmonary Disease
8.1.5.1. Market Revenue and Forecast (2017-2027)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2027)
Chapter 9. U.S. Complex & Chronic Condition Management Market, By Service
9.1. Complex & Chronic Condition Management Market, by Service, 2021-2027
9.1.1. Consulting Service
9.1.1.1. Market Revenue and Forecast (2017-2027)
9.1.2. Implementation Service
9.1.2.1. Market Revenue and Forecast (2017-2027)
9.1.3. Education Service
9.1.3.1. Market Revenue and Forecast (2017-2027)
9.1.3.2.
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2027)
Chapter 10. U.S. Complex & Chronic Condition Management Market, U.S. Estimates and Trend Forecast
10.1. U. S.
10.1.1. Market Revenue and Forecast, by Disease (2017-2027)
10.1.2. Market Revenue and Forecast, by Service (2017-2027)
Chapter 11. Company Profiles
11.1. AllScripts
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Siemens Healthineers
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Koninklijke Philips N.V.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Pegasystems, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Cognizant TriZetto Software Group Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. IBM Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. ScienceSoft USA
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. MINES & Associates, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Healthcare at Home
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Mediware Information Systems
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1455
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://precedenceresearchnews.wordpress.com
